Loading Logo

Cilmed T (10/40)

Cilmed T (10/40)

Cilnidipine 10 mg & Telmisartan 40 mg Tablets

Cilmed-T 10/40 is a combination medication designed for the effective management of hypertension (high blood pressure). By combining a calcium channel blocker with an angiotensin II receptor blocker (ARB), it provides a dual mechanism to relax blood vessels and improve blood flow.

We’re Here to Help

Have questions or need guidance? Our experts are here to help with personalized solutions. Let's Talk!

Cilnidipine 10 mg & Telmisartan 40 mg Tablets

Cilmed-T 10/40 is a combination medication designed for the effective management of hypertension (high blood pressure). By combining a calcium channel blocker with an angiotensin II receptor blocker (ARB), it provides a dual mechanism to relax blood vessels and improve blood flow.

Product Overview

  • Brand Name: Cilmed-T 10/40
  • Composition: Cilnidipine IP (10 mg) + Telmisartan IP (40 mg)
  • Dosage Form: Film-coated tablets
  • Packaging: 10 x 10 Tablets (Alu-Alu blister packing for maximum stability)

Usage & Dosage

  • Indication:Treatment of hypertension.
  • Dosage: As directed by the physician.
  • Administration:Tablets should be swallowed whole and not crushed or chewed.

Important Safety Information

WARNING: Pregnancy When pregnancy is detected, Telmisartan should be discontinued as soon as possible as it can cause injury and even death to the developing fetus when used in pregnancy during the second and third trimesters.

  • Schedule H Drug:This is a prescription-only medication. To be sold by retail only on the prescription of a Registered Medical Practitioner.
  • Storage:Store in a cool, dry, and dark place. Keep the medicine out of reach of children.
  • Excipients:Contains Titanium Dioxide IP as a coloring agent.

Manufacturing & Marketing Information

  • Marketed by: Accuscope Pharma Pvt. Ltd. (Nashik, Maharashtra)
  • Manufactured by: ABOD Pharmaceuticals (ISO 9001:2015 & GMP Certified), Haridwar, Uttarakhand.
  • License No 6/UA/2025 & 7/UA/SC/P-2025
Brand Name

Composition

Dosage Form

Packaging

Recently Viewed Products

No recently viewed products to display